Swiss pharma lags behind in global innovation ranking
Pharmaceutical companies are currently among the most innovative firms in the world alongside tech and software giants such as Apple and Alphabet, according to the Boston Consulting Group (BCG). But Swiss pharma companies rank low in their latest Top 50 list.
This content was published on
2 minutes
Keystone-SDA/swissinfo/sb
Español
es
La farmacéutica suiza se rezaga en ranking de innovación
“Pharma companies performed strongly this year, joining technology and software companies that have dominated the rankings in recent years,” said BCG in a statementExternal link on Thursday. The group have released their “Most Innovative Companies 2021” report that features a Top 50 ranking.
In 2021, nine pharmaceutical companies were ranked by BCG experts among the 50 most innovative companies, three times more than the previous year.
US pharmaceutical companies Pfizer and Johnson & Johnson, which have developed vaccines against Covid-19, were ranked the 10th and 20th most innovative firms. Abbott Labs (29th) and Merck & Co (35th) also featured highly in the table that was topped by Apple, Alphabet, Amazon, Microsoft and Tesla.
Swiss pharmaceutical giants Novartis and Roche, which did not launch any Covid vaccines, were ranked 36th and 48th most innovative firms, respectively. They were nonetheless ahead of the British-Swedish multinational AstraZeneca (49th) and the German firm Bayer (50th).
More
More
Hear Swiss science stories for the world on our podcast ‘The Swiss Connection’
Why is Switzerland so sweet on cryptocurrency? What’s it like to be a Swiss expat in America? Swiss women couldn’t vote until when?!
While not at the forefront in developing vaccines, Swiss companies have been stepping up their involvement in manufacturing Covid-19 vaccines. Lonza is producing ingredients for the Moderna vaccine at its production plant in Visp, southern Switzerland, while pharma giant Novartis has signed deals to help manufacture both the Pfizer/BioNtech and CureVac vaccines. Roche has been focusing on Covid-19 tests and treatments.
The question of whether Switzerland should have developed its own Covid vaccines has been in the headlines in recent weeks. Swiss Health Minister Alain Berset has been caught up in a controversy for reportedly turning down an offer by Lonza to produce vaccines domestically.
Newspapers have claimed that in spring 2020 Berset missed the chance to secure a Swiss-based vaccine production line via Lonza. Berset has since said there was no clear connection between investing in Lonza and securing access to the Moderna vaccine.
A parliamentary commission plans to investigate the matter. It’s not known when their findings will be published.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss authorities announce cost-cutting in asylum sector
This content was published on
The government notably wants to improve integration into the labour force, particularly for people with protection status S.
Various leaders confirm participation at Ukraine peace conference
This content was published on
The presidents of Poland, Finland, and Latvia and the prime ministers of Spain and Belgium will be at the Swiss-hosted talks in mid-June.
This content was published on
In the winter season up to April 2024, railway and cable car operators ferried 3% more visitors compared to the previous winter, and 5% more than the five-year average.
Rhine flooding: Swiss to invest CHF1 billion with Austria
This content was published on
As part of an international agreement with Austria, the Swiss government wants to pump CHF1 billion ($1.1 billion) into flood protection measures along the Rhine over the next three decades.
Swiss government proposes CHF10 million UNRWA donation
This content was published on
After months of debate, Switzerland plans to give CHF10 million ($11 million) to the UN agency this year, rather than the CHF20 million initially foreseen.
Swiss study: insects mainly migrate at midday and dusk
This content was published on
A study led by the Swiss Ornithological Institute in canton Lucerne is helping to better understand the movement patterns of migratory insects.
Red Cross: 22 staff killed in Middle East since October
This content was published on
The Red Cross and Red Crescent network in Gaza and Israel has lost 22 staff members since last October, the Swiss Red Cross (SRC) said on Wednesday.
Dortmund’s Kobel is first Swiss goalie in Champions League final
This content was published on
Borussia Dortmund’s Gregor Kobel has achieved history by becoming the first Swiss goalkeeper to reach a Champion’s League final.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.